Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Sana Biotechnology Inc (SANA) – Sana Biotechnology Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Sana Biotechnology (SANA) trades at $3.07, down 2.23% on the day, reflecting ongoing investor caution despite a strong analyst consensus. The stock exhibits a bearish technical signal with significant negative cash flow and profitability metrics, including a -147.41% ROE. Recent business developments include promising preclinical data for its in-vivo CAR T therapy SG293 and a strategic collaboration with Mayo Clinic for type 1 diabetes, providing long-term catalysts amid near-term financial challenges.
The outlook balances high-potential clinical progress against substantial financial risk. Investment opportunity lies in the company's innovative cell therapy platform and overwhelmingly bullish analyst sentiment (82% Buy ratings), but is tempered by heavy cash burn, lack of profitability, and reliance on financing. The key risk is the company's ability to fund operations until its pipeline generates revenue.
Read full analysis

Key Stats

  • Market Cap
    $858.53M
  • Sector
    Health
  • 3M Drawdown
    -37.24%
  • Enterprise Value
    $832.72M
  • Dividend Yield
    -
  • Typical Hold Time
    7 days
$3.01
52W Low: $1.68
19 May 2025
52W High: $5.92
15 Oct 2025

Sana Biotechnology Inc (SANA) is currently valued at a market capitalization of $858.53M, with an enterprise value of $832.72M. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $1.68 and a high of $5.92, highlighting its annual price range. Over the past three months, Sana Biotechnology Inc has recorded a drawdown of -37.24%, reflecting recent price volatility. On average, investors hold Sana Biotechnology Inc for approximately 7 days, indicating typical investor behavior on the platform.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.


Technical Indicators
|
|
|
Overall Summary
Bearish (11)Neutral (12)Bullish (4)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $858.53M
  • Sector
    Health
  • 3M Drawdown
    -37.24%
  • Enterprise Value
    $832.72M
  • Dividend Yield
    -
  • Typical Hold Time
    7 days
$3.01
52W Low: $1.68
19 May 2025
52W High: $5.92
15 Oct 2025

Sana Biotechnology Inc (SANA) is currently valued at a market capitalization of $858.53M, with an enterprise value of $832.72M. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $1.68 and a high of $5.92, highlighting its annual price range. Over the past three months, Sana Biotechnology Inc has recorded a drawdown of -37.24%, reflecting recent price volatility. On average, investors hold Sana Biotechnology Inc for approximately 7 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!